Jenny Kobin | executive |
George Lasezkay | executive |
Charlie Deignan | executive |
Serge Belanger | analyst |
Jonathan Wolleben | analyst |
Jack Padovano | analyst |
Yi Chen | analyst |
Greetings and welcome to the Clearside Biomedical Third Quarter 2023 Financial Results and Corporate Update Call. [Operator Instructions] Please be advised that today's conference is being recorded.I will now like to turn the conference over to your speaker today, Jenny Kobin, Clearside Investor Relations. Ma'am, the floor is yours.
Good afternoon, everyone, and thank you for joining us on the call today.Before we begin, I would like to remind you that during today's call, we will be making certain forward-looking statements. Various remarks that we make during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.